Profound Medical (PROF)

• Market cap: $175M
• 1 day: -4.44%
• 5 days: -1.02%
• 1 month: -14.43%
• 3 months: 23.88%
• 6 months: -22.01%
• Year to date: -26.46%
• 1 year: -37.19%
• 5 years: -65.56%
• 10 years: -41.19%
• Sector: Healthcare
• Industry: Medical Devices

About: Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Employees: 142

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

18% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 11

0% more funds holding in top 10

Funds holding in top 10: 2 [Q4 2024] → 2 (+0) [Q1 2025]

3.14% less ownership

Funds ownership: 45.86% [Q4 2024] → 42.73% (-3.14%) [Q1 2025]

6% less funds holding

Funds holding: 52 [Q4 2024] → 49 (-3) [Q1 2025]

29% less capital invested

Capital invested by funds: $103M [Q4 2024] → $73.4M (-$29.7M) [Q1 2025]

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

77% less call options, than puts

Call options by funds: $21K | Put options by funds: $93K

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $11 89% upside
• Avg. target: $11 89% upside
• High target: $11 89% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Lake Street Benjamin Haynor

89% upside $11

Buy Maintained

23 Apr 2025